Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative platelet-rich plasma after arthroscopic surgery for osteochondral lesion of the talus
IRCT20230227057547N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2020
- Countries
- 1
01
Overview
Phase 3, open-label trial of platelet-rich plasma in osteochondral lesion of the talus (OLT) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: AOFAS score and VAS score. Started Mar 2020; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
osteochondral lesion of the talus (OLT)
Beyond the preview
Go deeper on IRCT20230227057547N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230227057547N1.